Latest Insider Transactions at Roivant Sciences Ltd. (ROIV)
This section provides a real-time view of insider transactions for Roivant Sciences Ltd. (ROIV). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Roivant Sciences Ltd. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Roivant Sciences Ltd.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 22
2023
|
Vivek Ramaswamy > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
4,000,000
-6.85%
|
$28,000,000
$7.95 P/Share
|
|
Jan 24
2023
|
Rakhi Kumar Chief Accounting Officer |
SELL
Other acquisition or disposition
|
Direct |
1,838
-1.35%
|
$14,704
$8.56 P/Share
|
|
Jan 24
2023
|
Matthew Gline CEO |
SELL
Other acquisition or disposition
|
Direct |
15,594
-1.39%
|
$124,752
$8.56 P/Share
|
|
Jan 24
2023
|
Eric Venker President & COO |
SELL
Other acquisition or disposition
|
Direct |
13,057
-1.79%
|
$104,456
$8.56 P/Share
|
|
Jan 05
2023
|
Eric Venker President & COO |
SELL
Open market or private sale
|
Direct |
24,037
-3.19%
|
$192,296
$8.02 P/Share
|
|
Jan 03
2023
|
James C Momtazee |
BUY
Grant, award, or other acquisition
|
Direct |
2,447
+3.93%
|
-
|
|
Jan 03
2023
|
Ilan Oren |
BUY
Grant, award, or other acquisition
|
Direct |
2,010
+3.23%
|
-
|
|
Jan 03
2023
|
Eric Venker President & COO |
SELL
Open market or private sale
|
Direct |
95,484
-11.25%
|
$668,388
$7.32 P/Share
|
|
Dec 30
2022
|
Eric Venker President & COO |
SELL
Open market or private sale
|
Direct |
23,761
-2.72%
|
$190,088
$8.0 P/Share
|
|
Dec 23
2022
|
Eric Venker President & COO |
SELL
Other acquisition or disposition
|
Direct |
16,031
-1.75%
|
$112,217
$7.1 P/Share
|
|
Dec 23
2022
|
Rakhi Kumar Chief Accounting Officer |
SELL
Other acquisition or disposition
|
Direct |
1,592
-1.16%
|
$11,144
$7.1 P/Share
|
|
Dec 23
2022
|
Matthew Gline CEO |
SELL
Other acquisition or disposition
|
Direct |
19,408
-1.7%
|
$135,856
$7.1 P/Share
|
|
Dec 09
2022
|
Eric Venker President & COO |
SELL
Open market or private sale
|
Direct |
133,376
-13.05%
|
$933,632
$7.03 P/Share
|
|
Dec 08
2022
|
Eric Venker President & COO |
SELL
Open market or private sale
|
Direct |
11,729
-1.13%
|
$82,103
$7.0 P/Share
|
|
Nov 20
2022
|
Eric Venker President & COO |
SELL
Other acquisition or disposition
|
Direct |
16,003
-1.52%
|
$80,015
$5.0 P/Share
|
|
Nov 20
2022
|
Matthew Gline CEO |
SELL
Other acquisition or disposition
|
Direct |
19,373
-1.66%
|
$96,865
$5.0 P/Share
|
|
Nov 20
2022
|
Rakhi Kumar Chief Accounting Officer |
SELL
Other acquisition or disposition
|
Direct |
1,584
-1.14%
|
$7,920
$5.0 P/Share
|
|
Nov 10
2022
|
Svf Investments (Uk) LTD |
SELL
Open market or private sale
|
Indirect |
4,343,919
-4.37%
|
$17,375,676
$4.75 P/Share
|
|
Nov 10
2022
|
Keith S Manchester |
SELL
Open market or private sale
|
Indirect |
3,922,504
-3.93%
|
$15,690,016
$4.75 P/Share
|
|
Nov 10
2022
|
Daniel Allen Gold |
SELL
Open market or private sale
|
Indirect |
5,656,081
-4.02%
|
$22,624,324
$4.75 P/Share
|
|
Nov 10
2022
|
Daniel Allen Gold |
SELL
Bona fide gift
|
Direct |
750,000
-93.5%
|
-
|
|
Nov 10
2022
|
Qvt Financial LP |
SELL
Open market or private sale
|
Indirect |
5,656,081
-4.02%
|
$22,624,324
$4.75 P/Share
|
|
Nov 10
2022
|
Dexcel Pharma Technologies Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
4,000,000
+3.74%
|
$20,000,000
$5.0 P/Share
|
|
Nov 09
2022
|
Keith S Manchester |
SELL
Other acquisition or disposition
|
Indirect |
1,196,200
-3.01%
|
-
|
|
Nov 09
2022
|
Daniel Allen Gold |
SELL
Other acquisition or disposition
|
Indirect |
1,196,200
-3.01%
|
-
|
|
Nov 09
2022
|
Qvt Financial LP |
SELL
Other acquisition or disposition
|
Indirect |
1,196,200
-3.01%
|
-
|
|
Oct 31
2022
|
James C Momtazee |
BUY
Grant, award, or other acquisition
|
Direct |
3,404
+5.61%
|
-
|
|
Oct 31
2022
|
Ilan Oren |
BUY
Grant, award, or other acquisition
|
Direct |
2,796
+4.59%
|
-
|
|
Oct 25
2022
|
Eric Venker President & COO |
SELL
Open market or private sale
|
Direct |
15,922
-1.49%
|
$63,688
$4.4 P/Share
|
|
Oct 25
2022
|
Rakhi Kumar Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,588
-1.13%
|
$6,352
$4.4 P/Share
|
|
Oct 25
2022
|
Matthew Gline CEO |
SELL
Open market or private sale
|
Direct |
19,276
-1.63%
|
$77,104
$4.4 P/Share
|
|
Oct 16
2022
|
James C Momtazee |
BUY
Grant, award, or other acquisition
|
Direct |
1,594
+2.07%
|
-
|
|
Sep 23
2022
|
Eric Venker President & COO |
SELL
Open market or private sale
|
Direct |
17,392
-1.61%
|
$52,176
$3.07 P/Share
|
|
Sep 23
2022
|
Rakhi Kumar Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,741
-1.22%
|
$5,223
$3.07 P/Share
|
|
Sep 23
2022
|
Matthew Gline CEO |
SELL
Open market or private sale
|
Direct |
21,053
-1.75%
|
$63,159
$3.07 P/Share
|
|
Sep 15
2022
|
Ilan Oren |
BUY
Grant, award, or other acquisition
|
Direct |
52,142
+48.5%
|
-
|
|
Sep 15
2022
|
James C Momtazee |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+48.11%
|
-
|
|
Sep 15
2022
|
Keith S Manchester |
BUY
Grant, award, or other acquisition
|
Direct |
52,142
+50.0%
|
-
|
|
Sep 15
2022
|
Andrew Lo |
BUY
Grant, award, or other acquisition
|
Direct |
52,142
+50.0%
|
-
|
|
Sep 15
2022
|
Daniel Allen Gold |
BUY
Grant, award, or other acquisition
|
Direct |
52,142
+50.0%
|
-
|
|
Aug 24
2022
|
Eric Venker President & COO |
SELL
Open market or private sale
|
Direct |
16,530
-1.5%
|
$49,590
$3.71 P/Share
|
|
Aug 24
2022
|
Rakhi Kumar Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,652
-1.14%
|
$4,956
$3.71 P/Share
|
|
Aug 24
2022
|
Matthew Gline CEO |
SELL
Open market or private sale
|
Direct |
20,009
-1.63%
|
$60,027
$3.71 P/Share
|
|
Jul 25
2022
|
Eric Venker President & COO |
SELL
Open market or private sale
|
Direct |
16,896
-1.51%
|
$67,584
$4.33 P/Share
|
|
Jul 25
2022
|
Rakhi Kumar Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,686
-1.15%
|
$6,744
$4.33 P/Share
|
|
Jul 25
2022
|
Matthew Gline CEO |
SELL
Open market or private sale
|
Direct |
20,455
-1.64%
|
$81,820
$4.33 P/Share
|
|
Jul 20
2022
|
Ilan Oren |
BUY
Grant, award, or other acquisition
|
Direct |
3,223
+50.0%
|
-
|
|
Jul 20
2022
|
James C Momtazee |
BUY
Grant, award, or other acquisition
|
Direct |
3,923
+50.0%
|
-
|
|
Jun 23
2022
|
Eric Venker President & COO |
SELL
Open market or private sale
|
Direct |
16,402
-1.45%
|
$65,608
$4.34 P/Share
|
|
Jun 23
2022
|
Matthew Gline CEO |
SELL
Open market or private sale
|
Direct |
19,855
-1.57%
|
$79,420
$4.34 P/Share
|